Get started
Author

Peter J. Wyngaard

Identification of Targetable FGFR Gene Fusions in Diverse Cancers
2013 · Yi-Mi Wu, Fengyun Su, et al. · Cancer Discovery · 744
Development and Validation of a Scalable Next-Generation Sequencing System for Assessing Relevant Somatic Variants in Solid Tumors
2015 · Daniel H. Hovelson, Andrew S. McDaniel, et al. · Neoplasia · 224
Abstract 2897: Discovery and characterization of driver MAPK and PI3K pathway mutations in tumors and association with drug response in cell lines.
2013 · Mark Tomilo, Paul D. Williams, et al. · Cancer Research · 2
Abstract 3665: An EMT gene expression diagnostic predicts resistance to EGFR and MEK-targeted therapies in cell lines and patients
2012 · Sean F. Eddy, Paul Williams, et al. · Cancer Research · 2
Abstract 3664: Breast cancer companion diagnostic platform based on objectively defined tumor co-expression patterns stratifies multiple clinical and therapeutic endpoints comparison to existing molecular subtyping definitions
2012 · Daniel R. Rhodes, Scott Tomlins, et al. · Cancer Research · 2
Abstract C256: Expanded clinical opportunities for crizotinib from an analysis of over 5,000 cancer patient exomes.
2013 · Sean Eddy, Mark Tomilo, et al. · Molecular Cancer Therapeutics · 1
Abstract 3173: High-throughput, systematic analysis of paired-end next-generation sequencing data to characterize the gene fusion landscape in cancer.
2013 · Seth E. Sadis, Nickolay A. Khazanov, et al. · Cancer Research · 1
430 Analysis of 2,700 Cancer Exomes to Identify Novel Cancer Drivers and Therapeutic Opportunities
2012 · S.A. Tomlins, P. Wyngaard, et al. · European Journal of Cancer · 1
Supplementary Figures from Identification of Targetable FGFR Gene Fusions in Diverse Cancers
2023 · Yi-Mi Wu, Fengyun Su, et al.
Supplementary Tables from Identification of Targetable FGFR Gene Fusions in Diverse Cancers
2023 · Yi-Mi Wu, Fengyun Su, et al.
PDF
Supplementary Figures from Identification of Targetable FGFR Gene Fusions in Diverse Cancers
2023 · Yi-Mi Wu, Fengyun Su, et al.
PDF
Supplementary Tables from Identification of Targetable FGFR Gene Fusions in Diverse Cancers
2023 · Yi-Mi Wu, Fengyun Su, et al.
Data from Identification of Targetable FGFR Gene Fusions in Diverse Cancers
2023 · Yi-Mi Wu, Fengyun Su, et al.
Data from Identification of Targetable FGFR Gene Fusions in Diverse Cancers
2023 · Yi-Mi Wu, Fengyun Su, et al.
A survey of thousands of tumor exomes and transcriptomes to expand clinical opportunities for crizotinib.
2013 · Emma Bowden, Sean Eddy, et al. · Journal of Clinical Oncology
492 Frequency and Co-occurrence of MAPK and PI3K Pathway Driver Mutations to Guide Single-agent and Combination Therapies: an Analysis of Next Generation Sequence Data From 2700 Patients
2012 · E.T. Bowden, P. Wyngaard, et al. · European Journal of Cancer
A qPCR gene expression module test to predict resistance to cetuximab in colorectal cancers independent of KRAS mutation status.
2012 · Dan Rhodes, Sean Eddy, et al. · Journal of Clinical Oncology
Abstract A19: A qPCR assay, OncoScore Colon, predicts resistance to cetuximab in formalin-fixed, paraffin-embedded colorectal cancer tissue independent of KRAS status
2012 · Sean Eddy, Byung-In Lee, et al. · Clinical Cancer Research
P1-07-04: Gene Expression Module Biomarkers To Stratify Multiple Clinical and Therapeutic Endpoints for Universal Breast Cancer Companion Diagnostic.
2011 · D Rhodes, S Tomlins, et al. · Cancer Research
Abstract CN07-02: Target discovery with Oncomine: Discovering new targets and positioning old targets by integrative analysis of 10,000s of tumor genomes and transcriptomes.
2011 · Daniel R. Rhodes, Matthew A. Anstett, et al. · Molecular Cancer Therapeutics
Abstract B27: OncoPredictor: High copy number gain of ERBB2 predicts sensitivity to lapatinib.
2011 · Sean F. Eddy, Mark Tomilo, et al. · Molecular Cancer Therapeutics
PP 21 Gene expression module biomarkers to stratify multiple clinical and therapeutic endpoints for universal breast cancer companion diagnostic
2011 · B. Lee, S. Tomlins, et al. · European Journal of Cancer
Association of gene expression module biomarkers with clinical and therapeutic endpoints and their use with a universal companion diagnostic assay.
2011 · S. A. Tomlins, P. Williams, et al. · Journal of Clinical Oncology
Identification of breast cancer genomic subtypes that associate with prognosis and response to therapy in retrospective analyses.
2011 · D. Rhodes, S. A. Tomlins, et al. · Journal of Clinical Oncology
Abstract LB-224: Development of a novel breast cancer segregation panel assay for multiple genetic subtyping based on gene expression modules developed from Oncomine™
2011 · Kahuku Oades, Sukla Chattopadhyay, et al. · Cancer Research
Works count: 30
Citation count: 977
H-index: 2
I10-index: 2
Year
Topic
Type